Peter Maurus, MD
Foot and Ankle Surgery · North Liberty, IANPI 1881602050
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Stryker at 46.2% of the total. Reporting peaked in 2023 at $10,857 and has fallen 93.2% since, to $739 in 2025.
Across 63 payments — averaging $271.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Medical Device Business Services, Inc.$7K
- Synthes USA Products LLC$2K
- Wardlow Enterprises$204
- Organogenesis Inc.$83
- International Life Sciences$43
- plus $14 from 1 others
What the payments were for
- Consulting fees$6,97841%
- Travel & lodging$8,58250%
- Food & beverage$1,5289%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 47 | $7,902 |
| Medical Device Business Services, Inc. | 3 | $7,070 |
| Synthes USA Products LLC | 7 | $1,773 |
| Wardlow Enterprises | 2 | $204 |
| Organogenesis Inc. | 2 | $83 |
| International Life Sciences | 1 | $43 |
| Arthrex | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,088 in reported general payments places this provider in the 85th percentile of 112 foot and ankle surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 67 | $890 |
| Oxycodone Hcl | 139 | $836 |
| Cefadroxil | 35 | $328 |
| Diclofenac Sodium | 18 | $248 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $165 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $144 |
| Tramadol Hcl | 21 | $82 |
| Amoxicillin | 17 | $1 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in North Liberty
- Michael LeeDes Moines$2.1M
- Phinit PhisitkulSioux City$1.4M
- Sean GrambartDes Moines$590K
- Kelsey MillonigDes Moines$330K
- Charles CibulaCedar Falls$38K
- Gregory FooteWaterloo$35K
- Nathan ShumwayCouncil Bluffs$33K
- Justin RaatzDes Moines$28K
- Tuvi MendelDavenport$26K
- Mica MurdochDes Moines$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.